Looks like all they need is positive data from phase 2 and phase 3 trials involving several hundred patients and hundreds of millions of dollars, in an indication where all other drugs have failed.
still, it’s a step forward that they have manufactured some, although stability is not yet demonstrated.
I reckon a 5% chance of hitting the market in 10 years. But what do I know?
Ann: PRENUMBRA formulation completed for clinical trial use, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.87 |
Change
-0.180(1.28%) |
Mkt cap ! $695.5M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.11 | $13.75 | $452.7K | 32.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 275 | $13.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.89 | 177 | 7 |
View Market Depth
| Last trade - 12.35pm 20/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |